ArticleQatar medical journal2025

Enhancing the use of sodium-glucose cotransporter-2 inhibitors in type-2 diabetic patients with chronic kidney disease, through a key performance indicator program.

Muhammad Asim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.